Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2023

Stockholders' Equity Note [Abstract]

Schedule of Stock Options Activity

A summary of the stock option activity under the Company’s equity incentive plans is presented below:

	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Term	Aggregate Intrinsic Value
Balance as of December 31, 2022	3,976	$	6.20	3.80	$	—
Granted	—	—		—	—
Exercised	(34)	0.86		—	—
Forfeited	(52)	4.97		—	—
Expired	(95)	4.06		—	—
Balance as of March 31, 2023	3,795	$	6.31	3.53	$	6
Expected to vest at March 31, 2023	3,795	$	6.31	3.53	$	6
Exercisable at March 31, 2023	3,216	$	6.47	2.59	$	6

Schedule of RSU Activity

A summary of Restricted Stock Unit (“RSU”) activity is presented below:

	Shares	Weighted Average Grant- Date Fair Value
Outstanding as of December 31, 2022	7,495	$	3.59
Granted	—	—
Vested	(360)	4.65
Forfeited	(531)	5.03
Outstanding as of March 31, 2023	6,604	$	3.41

Summary of Stock-Based Compensation Expense

The following table summarizes stock-based compensation cost included in the condensed consolidated statements of operations:

	Three Months Ended March 31,
	2023		2022
Cost of revenue, excluding depreciation and amortization	$	356	$	460
Sales and marketing	569		722
General and administrative	542		2,598
Research and development1	(345)		160
Total	$	1,122	$	3,940

_________________________________

(1) The negative stock-based compensation expense for the three months ended March 31, 2023 for Research and development was due to forfeitures.